Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity

PurposeTo compare the efficacy of intravitreal ranibizumab (IVR) and conbercept (IVC) treatment for retinopathy of prematurity (ROP) and to evaluate the risk factors associated with disease reactivation.MethodsIn this retrospective study, the medical records of infants with ROP treated with IVR or I...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qiuhui Liu, Jing Li, Jiafen Liu, Suzhen Xie, Ge Mu, Huanhuan Zhao, Jiao Zheng, Xuelin Huang, Jianxun Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-02-01
Colecção:	Frontiers in Medicine
Assuntos:	anti-VEGF (vascular endothelial growth factor) conbercept ranibizumab reactivation ROP (retinopathy of preterm)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1754490/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!